Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Non-cash Items (2020 - 2025)

Historic Non-cash Items for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $21.0 million.

  • RxSight's Non-cash Items rose 51929.62% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 51929.62%. This contributed to the annual value of $15.0 million for FY2024, which is 8072.29% up from last year.
  • Per RxSight's latest filing, its Non-cash Items stood at $21.0 million for Q3 2025, which was up 51929.62% from $24.2 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Non-cash Items registered a high of $24.2 million during Q2 2025, and its lowest value of $3.0 million during Q2 2021.
  • Over the past 5 years, RxSight's median Non-cash Items value was $10.2 million (recorded in 2023), while the average stood at $12.0 million.
  • Per our database at Business Quant, RxSight's Non-cash Items plummeted by 6666.67% in 2021 and then soared by 51929.62% in 2025.
  • Over the past 5 years, RxSight's Non-cash Items (Quarter) stood at $8.8 million in 2021, then crashed by 30.68% to $6.1 million in 2022, then skyrocketed by 36.07% to $8.3 million in 2023, then surged by 80.72% to $15.0 million in 2024, then surged by 40.0% to $21.0 million in 2025.
  • Its Non-cash Items was $21.0 million in Q3 2025, compared to $24.2 million in Q2 2025 and $23.5 million in Q1 2025.